Jun 16, 2015Date: Thursday, 25th June, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: Simon Wilkinson, Managing Director and CEO of Innate Immunotherapeutics
"If Survival = Success, then Innate Immunotherapeutics is doing OK!"
New Zealand biotech company Innate Immunotherapeutics has not only survived since it was founded in Auckland 15 years ago, but it is now only 45 patients away from a possible “really good day at the office”. At least that’s the assessment of Innate’s CEO and Managing Director, Simon Wilkinson.
Innate was ‘born’ Virionyx Corporation, a New Zealand unlisted public company, developing a passive immunotherapeutic for HIV patients without small molecule treatment options. The HIV programme was “put down” in 2008 and the company refocused on a second technology which is now in Phase 2B proof of platform trials in Australia and New Zealand. Along the way the Company shifted its legal (but not management and operational) residence to Australia and listed on the ASX following a successful IPO of A$10 million in late 2013.
As a former naval officer, banker, and now biotech CEO, Simon will give us his unique take on Douglas Adams’ (Hitchhiker's Guide to the Galaxy) quote “I may not have gone where I intended to go, but I think I have ended up where I needed to be”.
Cancel all other plans, reply “yes” now – and we’ll see you next Thursday, 25 June for a highly enjoyable evening!
RSVP Please reply YES by email
Date and time 4.30 pm (for 5 pm presentation), Thursday 25 June, 2015.
Venue - Reception Lounge, at the main entrance to the Thomas Building, 3a Symonds St (map attached).
Parking - University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.